First-Line Therapy for Metastatic Non–Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches

At JADPRO Live 2019, Joshua Bauml, MD, and Christina Knepley, CRNP, discussed how to devise treatment plans for patients with metastatic non–small cell lung cancer, including using biomarkers to guide treatment selection, understanding clinical data supporting the use of targeted and immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauml, Joshua, Knepley, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857317/
https://www.ncbi.nlm.nih.gov/pubmed/33598322
http://dx.doi.org/10.6004/jadpro.2020.11.3.9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857317/
https://www.ncbi.nlm.nih.gov/pubmed/33598322
http://dx.doi.org/10.6004/jadpro.2020.11.3.9

Ejemplares similares